Uses of interferons with altered spatial structure
AssigneeSuperlab Far East Limited
InventorGuangwen Wei
Life of this patent
Estimating the term…
Abstract
This invention provides a method for preventing or treating Severe Acute Respiratory Syndrome in a subject comprising administering to the subject an effective amount of recombinant super-compound interferon or a functional equivalent thereof. This invention provides a method for inhibiting the causative agent of Severe Acute Respiratory Syndrome comprising contacting the agent with an effective amount of super-compound interferon or its equivalent.
Claims20
1-29. (canceled)
A method for treating prostate tumor in a subject comprising administering to the subject an effective amount of a recombinant interferon having an amino acid sequence of SEQ ID NO:2, wherein the recombinant interferon is produced by a method comprising the steps of:
- i) introducing into an E. coli host cell a polynucleotide comprising SEQ ID NO:1 that encodes the recombinant interferon, wherein the polynucleotide is cloned into an expression vector that allows expression of the recombinant interferon in the E. Coli host cell;
- ii) culturing the host cell in an appropriate condition for the expression of the recombinant interferon;
- and
- iii) harvesting the expressed recombinant interferon.
A method for treating prostate tumor in a subject comprising administering to the subject an effective amount of a recombinant interferon having an amino acid sequence of SEQ ID NO:2, wherein the recombinant interferon is produced by a method comprising the steps of:
- i) introducing into a host cell a polynucleotide comprising SEQ ID NO:1 that encodes the recombinant interferon;
- ii) culturing the host cell in an appropriate condition for the expression of the recombinant interferon;
- and
- iii) harvesting the expressed recombinant interferon.
A method for treating prostate tumor in a subject comprising administering to the subject an effective amount of a recombinant interferon, wherein the interferon has the amino acid sequence of SEQ ID NO:2 and is encoded by the nucleotide sequence SEQ ID NO:1.
Dependencies are inferred from the claim text.